Join Ian Churcher, VP Drug Discovery and Preclinical Development at BenevolentAI at the AI Summit London on Artificial Intelligence in Pharmaceuticals
About Ian Churcher
Ian is currently VP of Drug Discovery at BenevolentAI where he is applying a range of artificial intelligence approaches to all phases of drug discovery and development. Prior to this, for 5 years, he led the Protein Degradation Discovery Performance Unit at GSK, one of the pioneering groups who, working with Prof Craig Crews, demonstrated the application of Protac approaches to drug discovery. Ian has previously held a number of drug discovery & medicinal chemistry roles in GSK and Merck where he has always championed novel technologies and strategies to discover drugs. Ian was also a Visiting Professor in the Department of Chemistry at the University of Oxford from where he also holds MA and D.Phil degrees.
Want to meet us there? Contact us firstname.lastname@example.org